StatID PROâ„¢ COVID-19/Flu A&B
The StatID PRO COVID-19/Flu A&B is a lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly in anterior nasal swab samples from individuals with signs and symptoms of respiratory tract infection.
Why StatID PRO
COVID-19/Flu A&B?
StatID PRO COVID-19/Flu A&B combo rapid test delivers quick, reliable results for COVID-19, influenza A, and influenza B from a simple anterior nasal swab. FDA-cleared for use in patients 2 years and older, the test is designed for use within the first five days of symptoms. This easy-to-use rapid assay helps healthcare providers quickly differentiate between common respiratory infections with similar presentations.
One swab, three answers — COVID-19, Flu A, and Flu B antigen results
FDA-cleared, not EUA — trusted regulatory approval with proven reliability
Approved for use in patients 2 years and older
15-minute visual results for immediate decision-making
Workflow flexibility — specimens may be held in extraction tube for up to 1 hour before testing
Related Tests
Support & Documents
Downloadable PDFs
FAQs
What sample types can be used?
Anterior nasal swab sample type can be used with StatID PRO COVID-19/Flu A&B
Can samples in transport media be used?
No. For use with anterior nasal swab specimens only and not for use with viral transport media (VTM)
Does the StatID PRO COVID-19/Flu A&B kit include External Controls?
External controls are sold separately (StatID PRO COVID-19/Flu A&B Controls, Cat. #783010)
What is the suggested CPT code?
It is suggested to use CPT 87428, and for the CLIA waiver, add a QW designator
Pricing
- Email: sales@meridianbioscience.com
- Phone: +1 800 696-0739
- International Sales Extension: +1 513 271-3000
